![David Wang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Wang
Private Equity Investor chez
OrbiMed Advisors Private Equity
Profil
David Wang, M.D., Ph.D., is a Partner and Senior Managing Director on the Asia team, focused on Greater China.
Previously, he was a Managing Director at WI Harper Group, responsible for healthcare investments in China.
He also previously served as Head of Business Development at Siemens Medical Solutions, where he directed corporate strategy and new businesses in molecular diagnostics and diagnostic imaging.
Dr. Wang was a co-founder and EVP at First Genetic Trust, a personalized medicine company.
During his tenure at Bristol-Myers Squibb, Dr. Wang was Chairman of The SNP Consortium Management Committee, the first group of its kind formed by pharmaceutical and technology industries to support the development of personalized medicine.
He received his M.D.
from Peking University Medical School, and his doctorate in Developmental Biology from California Institute of Technology.
Postes actifs de David Wang
| Sociétés | Poste | Début |
|---|---|---|
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Private Equity Investor | 01/10/2019 |
Anciens postes connus de David Wang
| Sociétés | Poste | Fin |
|---|---|---|
Healthcare Royalty Partners
 Healthcare Royalty Partners Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 02/09/2019 |
Three Arch Partners
 Three Arch Partners Investment ManagersFinance Three Arch Partners invests in companies located in the US. The firm targets companies operating primarily in healthcare (medical devices, diagnostics and healthcare services) and occasionally biotechnology. The firm provides financing mainly on early stage companies and seldom on later stage healthcare companies. The firm has an investment range from $0.1 million to $15 million, believes in co-investing with other venture capital funds and remains actively involved in their companies. | Private Equity Investor | 02/04/2013 |
Access Closure, Inc.
 Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States | Directeur/Membre du Conseil | 01/03/2013 |
Formation de David Wang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Access Closure, Inc.
Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States | Health Technology |
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Three Arch Partners
Three Arch Partners Investment ManagersFinance Three Arch Partners invests in companies located in the US. The firm targets companies operating primarily in healthcare (medical devices, diagnostics and healthcare services) and occasionally biotechnology. The firm provides financing mainly on early stage companies and seldom on later stage healthcare companies. The firm has an investment range from $0.1 million to $15 million, believes in co-investing with other venture capital funds and remains actively involved in their companies. | Finance |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Healthcare Royalty Partners
Healthcare Royalty Partners Investment ManagersFinance Functions as an alternative investment manager | Finance |
